Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Rhea-AI Summary

Exagen Inc. (Nasdaq: XGN) will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13-14, 2024, in Snowbird, Utah. Exagen's President and CEO, John Aballi, and CFO, Kamal Adawi, will hold one-on-one meetings with investors during the event.

CARLSBAD, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 13-14, 2024 in Snowbird, Utah. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Exagen’s Chief Financial Officer, will be participating in one-on-one meetings with investors during the event; meetings can be requested through BTIG.

About Exagen Inc.

Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.

For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).

Contact:
Ryan Douglas
Exagen Inc.
ir@exagen.com
760.560.1525

FAQ

When and where will the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference take place?

The conference will take place on February 13-14, 2024, in Snowbird, Utah.

Who will be participating in one-on-one meetings with investors during the event?

Exagen's President and CEO, John Aballi, and CFO, Kamal Adawi, will be participating in one-on-one meetings with investors.

How can investors request meetings with Exagen during the event?

Investors can request meetings with Exagen through BTIG.